Outcome of Combination Therapy with Sofosbuvir and Ledipasvir for Chronic Type C Liver Disease

Satoru Hagiwara,Naoshi Nishida,Tomohiro Watanabe,Toshiharu Sakurai,Hiroshi Ida,Yasunori Minami,Masahiro Takita,Tomohiro Minami,Mina Iwanishi,Hirokazu Chishina,Kazuomi Ueshima,Yoriaki Komeda,Tadaaki Arizumi,Masatoshi Kudo

Outcome of Combination Therapy with Sofosbuvir and Ledipasvir for Chronic Type C Liver Disease

2017

Satoru Hagiwara
Naoshi Nishida
Tomohiro Watanabe
Toshiharu Sakurai
Hiroshi Ida
Yasunori Minami
Masahiro Takita
Tomohiro Minami
Mina Iwanishi
Hirokazu Chishina
Kazuomi Ueshima
Yoriaki Komeda
Tadaaki Arizumi
Masatoshi Kudo

Introduction: Recently, the treatment of chronic hepatitis C has markedly advanced. A phase III clinical study of combination therapy with sofosbuvir (SOF) and le

Keywords:

Liver disease
Immunology
Medicine
Alternative medicine
Hepatitis C
Ledipasvir
Sofosbuvir
Combination therapy
treatment outcome
chronic hepatitis
clinical study
Internal medicine
Gastroenterology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations